{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:46:37Z","timestamp":1790772397009,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12032-019-1269-x","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:10:35Z","timestamp":1554837035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prospective assessment of taste impairment and nausea during radiotherapy for head and neck cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Stefania","family":"Martini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Carlo","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Arcadipane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Olivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Silvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Garzino Demo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Fasolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Pecorari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Airoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-0687","authenticated-orcid":false,"given":"Pierfrancesco","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"1269_CR1","first-page":"6247","volume":"35","author":"P Franco","year":"2015","unstructured":"Franco P, Potenza I, Schena M, Riva G, Pecorari G, Demo PG, et al. Induction chemotherapy and sequential concomitant chemo-radiation in locally advanced head and neck cancers: how induction-phase intensity and treatment breaks may impact on clinical outcomes. Anticancer Res. 2015;35:6247\u201354.","journal-title":"Anticancer Res"},{"key":"1269_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5301\/tj.5000525","volume":"102","author":"P Franco","year":"2016","unstructured":"Franco P, Fiorentino A, Dionisi F, et al. Combined modality therapy for thoracic and head and neck cancer: a review of updated literature based on a consensus meeting. Tumori. 2016;102:459\u201371.","journal-title":"Tumori"},{"key":"1269_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13014-014-0297-0","volume":"29","author":"P Franco","year":"2014","unstructured":"Franco P, Potenza I, Moretto F, Segantin M, Grosso M, Lombardo A, et al. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation of chemo-radiation: a single-arm prospective observational study. Radiat Oncol. 2014;29:297.","journal-title":"Radiat Oncol"},{"key":"1269_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12032-017-0950-1","volume":"34","author":"P Franco","year":"2017","unstructured":"Franco P, Martini S, Di Muzio J, Cavallin C, Arcadipane F, Rampino M, et al. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck. Med Oncol. 2017;34:81.","journal-title":"Med Oncol"},{"key":"1269_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00520-010-0902-1","volume":"18","author":"AJ Hovan","year":"2010","unstructured":"Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KEO, Elting LS, et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010;18:1081\u20137.","journal-title":"Support Care Cancer"},{"key":"1269_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1188\/13.ONF.E79-E85","volume":"40","author":"T Kano","year":"2013","unstructured":"Kano T, Kanda K. Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum. 2013;40:79\u201385.","journal-title":"Oncol Nurs Forum"},{"key":"1269_CR7","first-page":"22","volume":"35","author":"S Campagna","year":"2016","unstructured":"Campagna S, Gonnella S, Stuardi M, Sperlinga R, Cerponi M, Olivero M, et al. Italian validation of the chemotherapy induced taste alteration scale. Assist Inferm Ric. 2016;35:22\u20138.","journal-title":"Assist Inferm Ric"},{"key":"1269_CR8","first-page":"235","volume":"2","author":"E Sozeri","year":"2016","unstructured":"Sozeri E, Kutluturkan S. The validity and reliability of turkish version of the chemotherapy-induced taste alteration scale (CiTAS). Clin Nurs Res. 2016;2:235\u201349.","journal-title":"Clin Nurs Res"},{"key":"1269_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00520-018-4586-2","volume":"27","author":"E McKenzie","year":"2019","unstructured":"McKenzie E, Zaki P, Raman S, Olson R, McFarlane T, DeAngelis C, et al. Radiation-induced nausea and vomiting: a comparison between MASCC\/ESMO, ASCO, and NCCN antiemetic guidelines. Support Care Cancer. 2019;27:783\u201391.","journal-title":"Support Care Cancer"},{"key":"1269_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2012.02.031","volume":"84","author":"K Dennis","year":"2012","unstructured":"Dennis K, Zhang L, Lutz S, van Baardwijk A, van der Linden Y, Holt T, et al. International patterns of practice in the management of radiation therapy-induced nausea and vomiting. Int J Radiat Oncol Biol Phys. 2012;84:49\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1269_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.radonc.2009.11.001","volume":"94","author":"E Maranzano","year":"2010","unstructured":"Maranzano E, De Angelis V, Pergolizzi S, Lupattelli M, Frata P, Spagnesi S, et al. A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol. 2010;94:36\u201341.","journal-title":"Radiother Oncol"},{"key":"1269_CR12","first-page":"1291","volume":"19","author":"A Giacosa","year":"2015","unstructured":"Giacosa A, Morazzoni P, Bombardelli E, Riva A, Bianchi Porro G, Rondanelli M. Can nausea and vomiting be treated with ginger extract? Eur Rev Med Pharmacol Sci. 2015;19:1291\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1269_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.radonc.2007.12.030","volume":"87","author":"AT Monroe","year":"2008","unstructured":"Monroe AT, Reddy SC, Gibbs GL, White GA, Peddada AV. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy. Radiother Oncol. 2008;87:188\u201394.","journal-title":"Radiother Oncol"},{"key":"1269_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/154405910508400105","volume":"84","author":"SM Heckmann","year":"2005","unstructured":"Heckmann SM, Hujoel P, Habiger S, Friess W, Wichmann M, Heckmann JG, et al. Zinc gluconate in the treatment of dysgeusia\u2014a randomized clinical trial. J Dent Res. 2005;84:35\u20138.","journal-title":"J Dent Res"},{"key":"1269_CR15","first-page":"68","volume":"7","author":"MY Halyard","year":"2009","unstructured":"Halyard MY. Taste and smell alterations in cancer patients\u2014real problems with few solutions. J Support Oncol. 2009;7:68\u20139.","journal-title":"J Support Oncol"},{"key":"1269_CR16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1200\/JCO.2008.19.2690","volume":"27","author":"S Steinback","year":"2009","unstructured":"Steinback S, Hummel T, B\u00f6hner C, Berktold S, Hundt W, Kriner M, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol. 2009;27:1899\u2013905.","journal-title":"J Clin Oncol"},{"key":"1269_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ctrv.2014.06.011","volume":"40","author":"E Irune","year":"2014","unstructured":"Irune E, Dwivedi RC, Nutting CM, Harrington KJ. Treatment-related dysgeusia in head and neck cancer patients. Cancer Treat Rev. 2014;40:1106\u201317.","journal-title":"Cancer Treat Rev"},{"key":"1269_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/1097-0142(19830301)51:5<811::AID-CNCR2820510511>3.0.CO;2-M","volume":"51","author":"JD Chencharick","year":"1983","unstructured":"Chencharick JD, Mossman KL. Nutritional consequences of the radiotherapy of head and neck cancer. Cancer. 1983;51:811\u20135.","journal-title":"Cancer"},{"key":"1269_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00005537-200001000-00018","volume":"110","author":"A Graeff de","year":"2000","unstructured":"de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110:98\u2013106.","journal-title":"Laryngoscope"},{"key":"1269_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0936-6555(02)00418-1","volume":"15","author":"T Rampling","year":"2003","unstructured":"Rampling T, King H, Mais KL, Humphris GM, Swindell R, Sykes A, et al. Quality of life measurement in the head and neck cancer radiotherapy clinic: is it feasible and worthwhile? Clin Oncol. 2003;15:205\u201310.","journal-title":"Clin Oncol"},{"key":"1269_CR21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.otohns.2006.06.1266","volume":"135","author":"SE Mowry","year":"2006","unstructured":"Mowry SE, LoTempio MM, Sadeghi A, Wang KH, Wang MB. Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiation. Otolaryngol Head Neck Surg. 2006;135:565\u201370.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1269_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ijrobp.2007.12.054","volume":"72","author":"FM Fang","year":"2008","unstructured":"Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy: a longitudinal study. Int J Radiat Oncol Biol Phys. 2008;72:356\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1269_CR23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00520-011-1236-3","volume":"20","author":"JL Ryan","year":"2012","unstructured":"Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012;20:1479\u201389.","journal-title":"Support Care Cancer"},{"key":"1269_CR24","first-page":"14","volume":"9","author":"W Marx","year":"2014","unstructured":"Marx W, McCarthy AL, Ried K, Vitetta L, McKavanagh D, Thomson D, et al. Can ginger ameliorate chemotherapy-induced nausea? Protocol of a randomized double blind, placebo-controlled trial. BMC Complement Altern Med. 2014;9:14\u2013134.","journal-title":"BMC Complement Altern Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1269-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T23:27:24Z","timestamp":1586302044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1269-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they do not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The present study has been reviewed and approved by the Internal Review Board of the Department of Oncology of the University of Turin at AOU Citta\u2019 della Salute e della Scienza, Turin, Italy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"44"}}